Raymond James upgrades Solaris Energy stock rating on contract visibility

Raymond James upgraded Solaris Energy Infrastructure to Strong Buy from Outperform and raised its price target to $113 from $102 after the stock fell about 25% in five days (a -28.5% weekly return). The firm cited roughly 91% of its 3.5 GW fleet under contract and full-deployment EBITDA potential of about $1.65 billion, up approximately $300 million from its September outlook. Solaris also reported Q3 2026 adjusted EPS of $0.45 versus $0.28 expected, revenue of $341.08 million versus $255.4 million expected, and record adjusted EBITDA of $136 million, though the stock declined amid concerns about capital spending and rising expectations.

Analysis

The key debate is not whether demand exists, but whether contracted capacity converts into distributable cash flow without a disproportionate increase in capital intensity. Contract coverage lowers utilization and payment risk, but does not by itself guarantee commissioning dates, customer take-up, or attractive returns on the turnkey scope that lifted the EBITDA opportunity. The gap between trailing EBITDA and the much larger 2029-based valuation denominator makes the apparent cheapness especially sensitive to execution and funding assumptions; the two multiples are not directly comparable.

The decline despite a strong quarter suggests investors may be discounting capex, cash conversion, or elevated expectations rather than disputing near-term operating momentum. That is the contrarian opportunity—but an analyst upgrade and earnings revisions are not independent proof that the selloff is overdone. In the next 1–3 months, deployment milestones, capex and financing disclosures, and revisions to cash-flow guidance matter more than another headline EBITDA beat. Over 6–18 months, successful delivery could reduce perceived project risk and support a valuation rerating; delays or heavier-than-expected investment could instead leave reported growth ahead of equity value creation. Verify customer concentration, remaining deployment capex, and funding sources in company filings before sizing.

Key Decisions for Investors

• Treat SEI as a conditional, staged long rather than buying solely on the price decline or the 2029 EBITDA multiple. Consider initiating only after confirming deployment schedules and capex/funding assumptions in filings; add if subsequent updates show contracted capacity converting on schedule and cash generation tracking EBITDA.
• Near-term catalyst watch: quarterly deployment progress, capex, operating cash flow, and any changes to full-deployment timing or customer commitments. A beat driven by revenue or EBITDA without improving cash conversion is not confirmation of the thesis.
• Falsify the long thesis if deployment slips, required investment rises materially without corresponding returns, or guidance/revisions weaken; also reassess if leverage or external funding needs increase. Contract coverage should not be treated as protection against those risks.
• The main near-term risk/reward is asymmetric only if execution holds: the sharp reset may create upside as uncertainty clears, but the analyst target relies on a forward earnings base several years out. Avoid extrapolating that target into a near-term fair-value anchor; there is insufficient information here to set a defensible price target or options structure.